PharmaDeals Reports

The Royalty Rate Report 2016 is the definitive guide for the industry and provides in-depth analysis of one of the most important but elusive components of a biopharma deal – the royalty rate.

The Royalty Rate Report 2016: A comprehensive assessment of valuation in the pharmaceutical sector
Key Benefits
  • First hand insight on royalty rates from deal-makers via our PharmaDeals survey
  • Gain opinions and advice from leading industry deal-makers who share their thoughts on royalty rates
  • Receive guidance on the best methodologies to use including benchmarking and expected net present value when calculating royalty rates for vital decision making
  • Understand the differences in perception of value between biotechs and pharmaceutical companies and how that impacts the value of a deal
  • Review actual royalty rate data supported by case histories and be better informed before negotiating your next deal

Published April 2016






Request more information
The report includes:
  • A historical overview of royalties, their relevance to the biopharma industry and the psychology of royalty structures
  • Introduction to methods for calculating useful financial data missing from the public domain - essential for dealmakers in benchmarking and determining value in a deal and its relationship with future royalty streams
  • Thought leadership in determining royalty rates including the concept of effective royalties in the analysis of deal structures; calculating royalty rates in biotechnology deals supported by key opinion leader insight
  • A detailed presentation of key methodologies - benchmarking and expected net present value - used in calculating royalty rates
  • Market data and current trends in royalty rate disclosure by development phase, by indication and by the top pharmaceutical companies
  • Industry perception of royalties including a review of the literature, discussion on tiered royalty rates and critical analysis of the results of the PharmaDeals Royalty Rates Survey
  • A comprehensive appendix includes a listing of all royalty reporting deals from the last 10 years.
Delivery:
  • One year subscription to the report published on the interactive online IMS Syndicated Analytics Library
  • IMS Syndicated Analytics Library offers full searchability including cut and create your own report
  • Export tables, figures and whole chapters into Excel, PowerPoint and Word
  • Nine language automatic translation – choose to view report in French, German, Chinese, Italian, Spanish, Japanese, Portuguese, Korean or Russian

Bookmarks

Bookmark PharmaDeals through one of these social networks.

PharmaDeals Trends and Analysis Series
Analysis of Deal Making in Vaccines
Analysis of Deals in Neurodegenerative Diseases
Analysis of Oncology Deals: Trends in Deal Structures and Valuations